Activated Clotting Time Testing Market

The activated clotting time (ACT) is a test that is used primarily to monitor high doses of unfractionated (standard) heparin therapy. Heparin is a drug that inhibits blood clotting (anticoagulant) and is usually given intravenously (IV) by injection or continuous infusion. High doses of heparin may be given during procedures that require that blood be prevented from clotting, such as heart bypass surgery.
Activated Clotting Time Testing Market contains market size and forecasts of Activated Clotting Time Testing in Global, including the following market information:
Global Activated Clotting Time Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Activated Clotting Time Testing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Optical Detection Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Activated Clotting Time Testing include Roche, Thermo Fisher Scientific, Abbott, Helena Laboratories, Sysmex, Medtronic, Instrumentation Laboratory, Diagnostica Stago and Werfen and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Activated Clotting Time Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Activated Clotting Time Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Activated Clotting Time Testing Market Segment Percentages, by Type, 2021 (%)
Optical Detection
Laser-based Detection
Mechanical Detection
Fluorescent Based Detection
Global Activated Clotting Time Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Activated Clotting Time Testing Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinical Laboratories
Ambulatory Surgical Center
Academic & Research Institutes
Others
Global Activated Clotting Time Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Activated Clotting Time Testing Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Activated Clotting Time Testing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Activated Clotting Time Testing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Thermo Fisher Scientific
Abbott
Helena Laboratories
Sysmex
Medtronic
Instrumentation Laboratory
Diagnostica Stago
Werfen
LabCorp